Hong Kong Trade Distributors Stock News

Bank of Qingdao Co., Ltd. has reported full-year 2025 results, with net income rising to CNY 5,187.74 million and basic earnings per share from continuing operations reaching CNY 0.85, both up from the prior year. This earnings improvement highlights stronger profitability and may prompt investors to reassess the bank’s earnings power and operational efficiency. We will now examine how this stronger full-year profit performance shapes Bank of Qingdao’s investment narrative and future...

Tongguan Gold Group's (HKG:340) stock is up by a considerable 27% over the past three months. Given that the market...

It is hard to get excited after looking at Zero Fintech Group's (HKG:93) recent performance, when its stock has...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

China Resources Mixc Lifestyle Services' (HKG:1209) stock is up by a considerable 14% over the past three months. Given...

Why Sands China is on investors’ radar Sands China (SEHK:1928) has drawn attention after recent share price weakness, with the stock showing negative returns over the past month, past 3 months and year, prompting closer scrutiny of its fundamentals. See our latest analysis for Sands China. With the share price at HK$17.03, Sands China has seen weaker momentum recently, with a 7 day share price return of 9.22% and a 30 day share price return of 14.76%, while the 1 year total shareholder return...

Air China (SEHK:753) has issued 2025 earnings guidance that points to a net loss of about CN¥1.3b to CN¥1.9b, which raises fresh questions about how quickly its profitability can stabilise. See our latest analysis for Air China. The earnings warning comes after a mixed share price run, with a 90 day share price return of 17.51% but a year to date share price return showing a 1.83% decline. At the same time, the 1 year total shareholder return of 46.33% indicates that longer term holders have...

Viewing insider transactions for HKT Trust and HKT Limited's ( HKG:6823 ) over the last year, we see that insiders were...

Key Insights The projected fair value for China State Construction International Holdings is HK$12.00 based on 2 Stage...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

InnoCare Pharma (SEHK:9969) is back in focus after the company projected an improvement in its 2025 financial performance, supported by stronger drug sales and an anticipated move into profitability for the first time. See our latest analysis for InnoCare Pharma. That profit outlook comes after a mixed share price run, with the latest close at HK$11.72. The 1 year total shareholder return of 111.93% contrasts with a 5 year total shareholder return decline of 44.06%. This suggests recent...

Zhejiang Leapmotor Technology (SEHK:9863) has detailed a domestic share subscription under its general mandate, highlighting state owned Jinyi High-Tech as an independent, non connected investor and stressing compliance with Hong Kong listing rules. See our latest analysis for Zhejiang Leapmotor Technology. At a latest share price of HK$42.42, Zhejiang Leapmotor Technology’s short term share price returns, including a 30 day share price return of a 14.41% decline and a 90 day share price...

Time Interconnect Technology (SEHK:1729) has reshaped its leadership with three new board appointments, bringing its Chief Operating Officer, its Executive Vice President for MedTech, and a healthcare academic leader formally into director roles. See our latest analysis for Time Interconnect Technology. The leadership reshuffle comes after a period of mixed share price momentum, with a 1 day share price return of 4.59% from a last close of HK$15.5, set against a 30 day share price return of...

Ascletis Pharma (SEHK:1672) is back in focus after reporting favorable long term safety data from its Phase III acne drug denifanstat and confirming that China’s regulator has accepted its New Drug Application. See our latest analysis for Ascletis Pharma. The acne data and NDA progress come on the back of an active few weeks across its GLP 1 and metabolic pipeline. The share price has moved accordingly, with a 30 day share price return of 19.79% and 90 day share price return of 40.67%, adding...

Key Insights Significantly high institutional ownership implies CK Asset Holdings' stock price is sensitive to their...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights The projected fair value for China Hongqiao Group is HK$65.71 based on 2 Stage Free Cash Flow to Equity...

HSC Resources Group Limited ( HKG:1850 ) shares have continued their recent momentum with a 26% gain in the last month...

Despite an already strong run, Lai Group Holding Company Limited ( HKG:8455 ) shares have been powering on, with a gain...

The market for International Housewares Retail Company Limited's ( HKG:1373 ) shares didn't move much after it posted...

Cornerstone Technologies Holdings Limited ( HKG:8391 ) shareholders should be happy to see the share price up 15% in...

Insiders who bought Solis Holdings Limited ( HKG:2227 ) stock in the last 12 months were richly rewarded last week. The...

Key Insights The considerable ownership by individual investors in Sinohope Technology Holdings indicates that they...

Hang Lung Properties Limited ( HKG:101 ) will pay a dividend of HK$0.40 on the 15th of June. This payment means that...